Clinical predication value of the ischemia modified albumin for acute coronary syndrome patients after the percutaneous coronary intervention
10.3760/cma.j.issn.1008-1372.2012.10.001
- VernacularTitle:缺血修饰白蛋白对急性冠脉综合征PCI术后的临床预测价值
- Author:
Min AI
;
Qinghua ZHANG
;
Changfu YAN
;
Fuchun XIA
;
Shuanglu ZHOU
;
Jian HE
;
Dingping GU
;
Guoqi FU
;
Kuan ZHANG
;
Jun JIANG
;
Tao LI
;
Jingmei YANG
- Publication Type:Journal Article
- Keywords:
Coronary artery disease/surgery;
Acute disease;
Syndrome;
Serum albumin;
Postoperative period;
Angioplasty,transluminal,percutaneous coronary;
Forecasting
- From:
Journal of Chinese Physician
2012;(10):1297-1299
- CountryChina
- Language:Chinese
-
Abstract:
Objective Exploring clinical prediction value of the ischemia modified albumin (IMA) for acute coronary syndrome (ACS) patients after the percutaneous coronary intervention (PCI).Methods A total of 109 cases of the PCI postoperative patients of ACS at the Panggang General Hospital from January 2010 to July 2012 were included.IMA was determined within 6 hours after admission,and standardized treatment after PCI.After a 6-month follow-up,they were divided into the event group and non-event group according to cardiovascular events occurrence.Results 101 cases were followed-up,including 26 cases of cardiovascular events (25.74％) and 75 cases of no cardiovascular events (74.26％).The left ventricular ejection fraction of the event group [(45 ± 7)％] was significantly lower than the non-event group [(52 ± 10) ％] (t =1.894,P ＜ 0.05).Serum IMA of the event group[(105.51 ± 13.26) U/ml]was significantly higher than the non-event group [(85.18 ± 11.36) U/ml] (t =7.3518,P ＜0.01).After controlling other cardiovascular risk factors,IMA was still independent risk factors for cardiovascular events (OR =1.69,95％ CI: 1.18 ～ 2.13,P =0.01).Conclusions IMA have very good clinical prediction value of cardiovascular events occurrence for ACS after PCI.
